Jessica Yingling, Ph.D.
Jessica Yingling, Ph.D. is the president of Little Dog Communications. Little Dog clients represent the full range of biotechnology companies and include those developing novel therapeutics, diagnostics, and devices that can make a meaningful difference in the lives of patients. Prior to Little Dog, Jessica was director of corporate communications at Fate Therapeutics. Jessica earned her Ph.D. in biomedical sciences from UC San Diego and a B.S. with honors in biochemistry from the University of Arizona.
Articles by Jessica:
-
Biotech Briefing: MedCrypt Protects Medical Devices from Cyber Attacks
Plus: Salk Institute elects new chairman and Biolinq secures funding for wireless biosensor patch for diabetes
Read More » -
Biotech Briefing: Heron Therapeutics’ Cinvanti Receives FDA Approval
Plus: Tear Film completes $9 million Series A financing and Senomyx expands “Cool Program”
Read More » -
Biotech Briefing: Progenity Raises $125 Million for Precision Diagnostics
Plus: UCSD study gives clue to how one tumor suppressor fuels cancer
Read More » -
Biotech Briefing: New TSRI App Provides Genetic Risk Score for Heart Disease
Plus: Two major bills affecting life sciences were signed into California law
Read More » -
Biotech Briefing: Salk Scientist’s Pursuit of Exercise Pill
Plus: Synthetic DNA developed for manomaterials in medicine, and clinical trail dashboard launched for stem cell-based treatments
Read More » -
Biotech Briefing: Illumina Ventures Closes $230 Million Fund to Invest in Genomics Startups
Plus: UC San Diego’s Stefan Savage has been awarded a “genius grant” from the MacArthur Foundation
Read More » -
Biotech Briefing: UC San Diego, Salk Scientists Awarded NIH Grants
Plus: TSRI’s HIV research center receives a $27 million grant, and California has a new stem cell law
Read More » -
Biotech Briefing: San Diego Launches Its Newest Business Accelerator Program
Plus: Mapp Bio receives a $46 million federal contract, and this year’s Nobel Prizes have been announced
Read More » -
Biotech Briefing: What Biotech Would Look Like Without Immigrants
Plus: A genetic test for Alzheimer’s, and how San Diego attracts the best biotech talent
Read More » -
Biotech Briefing: UC San Diego Gets $10M Contract from IBM
Plus: Biocom recognizes 15 leaders under 40, and a local startup gets funding to scale manufacturing of “miracle material”
Read More » -
Biotech Briefing: Ligand Announces Positive Data for Diabetes Drug
Plus: NuVasive expands its San Diego headquarters, and a new combo treatment shows promise for metastatic melanoma patients
Read More » -
Biotech Briefing: First Cell-Based Gene Therapy Approved in the United States
Plus: Your computer can help scientists with microbiome and autoimmune disease research
Read More » -
Biotech Briefing: TSRI Ranked Most Influential Research Institute in the World
Plus: San Diego biotech generates $33.6 billion, and gene editing targets RNA
Read More » -
Next Big Thing: 3-D Bioprinting
Scientists have managed to 3-D print living tissue and human organs
Read More » -
Protein: It’s Not Just for Dinner
Everything you never knew you wanted to know about proteins
Read More » -
25 VIPs
A curated list of the very important proteins San Diego scientists are studying right now
Read More »
